Harbarth S, Rohner P, Auckenthaler R, Safran E, Sudre P, Pittet D
Infection Control Program, Geneva University Hospitals, Switzerland.
Scand J Infect Dis. 1999;31(2):163-8. doi: 10.1080/003655499750006218.
In order to characterize the impact and pattern of Gram-negative bacteraemia (GNB) at a Swiss University hospital and to assess the effect of multi-resistance on mortality, we conducted a 6-y retrospective cohort study using linear regression and multivariate Cox-proportional hazard analysis. 1766 patients had 1835 episodes of GNB; 61% were community-acquired. The incidence of GNB increased linearly (r2 = 0.90, p = 0.014) from 7.07 episodes to 8.32 episodes per 1000 admissions, but this trend was no longer significant after adjustment for the number of blood cultures drawn/y. The in-hospital mortality for patients with GNB decreased from 20% in 1989 to 16% in 1994 (r2 = 0.94, p = 0.005). The risk ratio for death remained unchanged over the study period and was 7-fold higher for patients with GNB than for patients without GNB. Factors independently associated with an increased hazard of death after GNB were: severity of illness as measured by exposure to intensive care (hazard ratio [HR], 1.5); age = 66-79 y (HR 1.8); GNB due to Klebsiella spp. (HR 1.7) or Pseudomonas aeruginosa (HR 1.6); and polymicrobial infection (HR 1.6). Multi-resistance was not associated with an increased risk of death (HR 1.0). Although the crude mortality of GNB decreased, the population-attributable risk ratio for death remained significant. These data suggest the absence of a major impact of multi-resistant GNB on patient mortality.
为了描述瑞士一家大学医院革兰氏阴性菌血症(GNB)的影响和模式,并评估多重耐药对死亡率的影响,我们进行了一项为期6年的回顾性队列研究,采用线性回归和多变量Cox比例风险分析。1766例患者发生了1835次GNB发作;61%为社区获得性。GNB的发病率从每1000次入院7.07次线性增加至8.32次(r2 = 0.90,p = 0.014),但在调整每年血培养次数后,这一趋势不再显著。GNB患者的院内死亡率从1989年的20%降至1994年的16%(r2 = 0.94,p = 0.005)。在研究期间,死亡风险比保持不变,GNB患者的死亡风险比无GNB患者高7倍。与GNB后死亡风险增加独立相关的因素包括:通过入住重症监护病房衡量的疾病严重程度(风险比[HR],1.5);年龄66 - 79岁(HR 1.8);由克雷伯菌属(HR 1.7)或铜绿假单胞菌(HR 1.6)引起的GNB;以及多微生物感染(HR 1.6)。多重耐药与死亡风险增加无关(HR 1.0)。尽管GNB的粗死亡率有所下降,但人群归因死亡风险比仍然显著。这些数据表明多重耐药GNB对患者死亡率没有重大影响。